Vicarious Surgical receives continued listing standard notice from NYSE

Vicarious Surgical announced that on September 20, 2023, it received a notice from the New York Stock Exchange that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the company’s Class A common stock was less than $1.00 per share over a consecutive 30 trading-day period. The Notice does not result in the immediate delisting of the company’s Class A common stock from the NYSE. The company intends to respond to the NYSE within ten business days of receipt of the Notice affirming its intent to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard. Pursuant to the NYSE’s rules, the company has a six-month period following receipt of the Notice to regain compliance with the NYSE’s minimum share price requirement.